Evaluating the role of intra articular injection of platelet rich fibrin in the management of TMJ osteoarthritis: A STROBE compliant retrospective study.

AbstractOsteoarthritis is a debilitating disease. A number of treatments like conservative approach, minimally invasive procedures and surgical therapy have proved to be beneficial. However, there is no consensus regarding the use of a single modality of treatment. Our current study evaluates the role of intra articular injection iPRF along with arthrocentesis for the management of TMJ OA. A total of 130 patients were selected and divided into two groups, Group A (arthrocentesis only group) and Group B (arthrocentesis +i-PRF). Patients were evaluated for pain scores and maximal mouth opening. After 1 year mouth opening in arthrocentesis only group was 32.13 ±1.46mm compared to 36.48±0.89mm in the i-PRF group (p value<0.0001). There was a significant reduction in mouth opening in Group A from 6 months-1 year compared to Group B (p value<0.001).There was no statistical difference in mean VAS scores at the end of 6 months (p value 1.00). Addition of iPRF to arthrocentesis did not improve joint pain after 6 months. Nevertheless, repeated injections did have a beneficial effect in maximal mouth opening. Within the limitations of the study repeated injections of iPRF in conjunction with arthrocentesis might be recommended for the treatment of mild TMJ OA.
Source: Oral Surgery - Category: ENT & OMF Authors: Tags: ORIGINAL ARTICLE Source Type: research